RU96106584A - METHOD FOR TREATING RATER DISEASE - Google Patents

METHOD FOR TREATING RATER DISEASE

Info

Publication number
RU96106584A
RU96106584A RU96106584/14A RU96106584A RU96106584A RU 96106584 A RU96106584 A RU 96106584A RU 96106584/14 A RU96106584/14 A RU 96106584/14A RU 96106584 A RU96106584 A RU 96106584A RU 96106584 A RU96106584 A RU 96106584A
Authority
RU
Russia
Prior art keywords
disease
treating
days
rater
pyrogenal
Prior art date
Application number
RU96106584/14A
Other languages
Russian (ru)
Other versions
RU2104004C1 (en
Inventor
А.С. Губа
Original Assignee
А.С. Губа
Filing date
Publication date
Application filed by А.С. Губа filed Critical А.С. Губа
Priority to RU96106584/14A priority Critical patent/RU2104004C1/en
Priority claimed from RU96106584/14A external-priority patent/RU2104004C1/en
Application granted granted Critical
Publication of RU2104004C1 publication Critical patent/RU2104004C1/en
Publication of RU96106584A publication Critical patent/RU96106584A/en

Links

Claims (1)

Способ лечения болезни Рейтера путем назначения антибиотиков и проведения симптоматического лечения, отличающийся тем, что больному внутримышечно вводят пирогенал через 1 - 2 дня и препараты групп метронидазола и/или хинолонов ежедневно в терапевтических дозах, курс 3 - 6 месяцев, затем через 5 - 7 дневный перерыв больному внутримышечно вводят рофефин в дозе 4 - 6 г вместе с аутокровью в количестве 3 - 5 мл, через день, курс 2 - 6 недель, после чего делают перерыв 7 - 8 дней и повторно вводят пирогенал по прежней схеме вместе с тетрациклинами ежедневно в терапевтических дозах в течение 2 - 3 недель.A method of treating Reiter’s disease by prescribing antibiotics and symptomatic treatment, characterized in that the patient is injected intramuscularly with pyrogenal after 1 to 2 days and drugs of the metronidazole and / or quinolone groups daily in therapeutic doses, the course is 3 to 6 months, then after 5 to 7 days break the patient intramuscularly administered rofefin in a dose of 4-6 g, together with autoblood in the amount of 3-5 ml, every other day, a course of 2-6 weeks, after which they take a break of 7-8 days and reintroduce pyrogenal according to the previous scheme together with tetracyclines daily therapeutic doses for 2 - 3 weeks.
RU96106584/14A 1996-04-04 1996-04-04 Method to treat reiter's disease RU2104004C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96106584/14A RU2104004C1 (en) 1996-04-04 1996-04-04 Method to treat reiter's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96106584/14A RU2104004C1 (en) 1996-04-04 1996-04-04 Method to treat reiter's disease

Publications (2)

Publication Number Publication Date
RU2104004C1 RU2104004C1 (en) 1998-02-10
RU96106584A true RU96106584A (en) 1998-05-10

Family

ID=20178943

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96106584/14A RU2104004C1 (en) 1996-04-04 1996-04-04 Method to treat reiter's disease

Country Status (1)

Country Link
RU (1) RU2104004C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2580301C1 (en) * 2015-04-21 2016-04-10 Людмила Николаевна Хон Method for treatment of human systemic lupus erythematosus

Similar Documents

Publication Publication Date Title
Bevelander et al. The effect of the administration of tetracycline on the development of teeth
RU2012106620A (en) COMBINATIONS AND METHODS OF INTRODUCING THERAPEUTIC MEDICINES AND COMBINED THERAPY
CY1111088T1 (en) PHARMACEUTICAL FORM FOR TOLTERODIN ADMINISTRATION WITH CONTROLLED LIBERTY
NO20014842L (en) Docet shaft in combination with rhuMAb HER2 for the treatment of cancer
Sillanpää Clonidine prophylaxis of childhood migraine and other vascular headache: a double blind study of 57 children
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
RU95101385A (en) Products containing g-csf and tnf-binding protein
AR023185A1 (en) CANCER TREATMENT IMPROVED WITH TEMOZOLOMIDE
RU96106584A (en) METHOD FOR TREATING RATER DISEASE
DE60008293D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A NO DONOR AND ITS THERAPEUTIC USE
DE69434002D1 (en) 2,3 DIARYL-1-BENZOPYRAME FOR TREATING DERMATITIS
US5081129A (en) Method of treatment of anemia with seratonin antagonists
RU2003134216A (en) METHOD FOR TREATING OSTEOCHONDROSIS OF SPINE BY SHORT INTENSIVE COURSES
RU97109989A (en) METHOD FOR TREATING VAGINOSIS AND VAGINITIS IN PREGNANT WOMEN
Finch Therapeutic targets in Alzheimer's disease: Suggestions for the NIA.
SU874037A1 (en) Method of eliminating cleft palate
RU2004243C1 (en) Method for treating psoriasis
SU1380752A1 (en) Method of tuberculinotherapy
RU94045317A (en) Method for treatment of encephalomyelitis
UA31638A (en) METHOD OF TREATMENT OF UVEITS
RU2003124971A (en) METHOD FOR TREATING PATIENTS WITH NEUROTIC AND SOMATOFORM DISORDERS
RU94025799A (en) Method of treatment of idiopathic dermatomyositis
UA29910A (en) A METHOD OF TREATMENT OF DYSFUNCTION OF THE PARTIAL-LOWER-JAW JOINT
RU95106400A (en) Method of prevention and treatment of diphtheria neuropathy in experiment
RU94013606A (en) Hemostimulator